AC015987.2 | | Predicted membrane proteins
| | | | | Expressed in all |
AC018867.2 | | Predicted membrane proteins
| | | | | Group enriched |
AC021218.2 | Uncharacterized protein | | | | | | Tissue enhanced |
AC024580.1 | Uncharacterized protein | | | | | | Mixed |
AC024592.12 | Uncharacterized protein | Predicted membrane proteins
| | | | | Mixed |
AC027763.2 | Uncharacterized protein | | | | | | Expressed in all |
AC068533.7 | | | | | | | Mixed |
AC079354.2 | Uncharacterized protein | Predicted secreted proteins
| | | | | Mixed |
AC079602.1 | | | | | | | Tissue enhanced |
AC090186.1 | Uncharacterized protein | | | | | | Expressed in all |
AC106876.2 | Uncharacterized protein | | | | | | Group enriched |
AC110619.2 | Uncharacterized protein | | | | | | Tissue enhanced |
AC114546.1 | HCG37415; PRO1914; Uncharacterized protein | | | | | | Tissue enhanced |
AC119673.1 | | | | | | | Mixed |
AC136297.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AC138517.1 | Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AC139100.2 | Uncharacterized protein | | | | | | Mixed |
ACAA1 | Acetyl-CoA acyltransferase 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
ACAA2 | Acetyl-CoA acyltransferase 2 | Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
ACACA | Acetyl-CoA carboxylase alpha | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ACACB | Acetyl-CoA carboxylase beta | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACAD10 | Acyl-CoA dehydrogenase family, member 10 | | | | | | Expressed in all |
ACAD11 | Acyl-CoA dehydrogenase family, member 11 | | | | | | Expressed in all |
ACAD8 | Acyl-CoA dehydrogenase family, member 8 | Disease related genes Mitochondrial proteins
| | | | | Expressed in all |
ACAD9 | Acyl-CoA dehydrogenase family, member 9 | Disease related genes Mitochondrial proteins
| | | | | Expressed in all |
ACADM | Acyl-CoA dehydrogenase, C-4 to C-12 straight chain | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
ACADS | Acyl-CoA dehydrogenase, C-2 to C-3 short chain | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
ACADSB | Acyl-CoA dehydrogenase, short/branched chain | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
ACADVL | Acyl-CoA dehydrogenase, very long chain | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
ACAP1 | ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
ACAP2 | ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 | Plasma proteins
| | | | | Expressed in all |
ACAP3 | ArfGAP with coiled-coil, ankyrin repeat and PH domains 3 | | | | | | Expressed in all |
ACAT1 | Acetyl-CoA acetyltransferase 1 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
ACAT2 | Acetyl-CoA acetyltransferase 2 | Enzymes Plasma proteins
| | | | | Expressed in all |
ACBD3 | Acyl-CoA binding domain containing 3 | Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
ACBD4 | Acyl-CoA binding domain containing 4 | Predicted membrane proteins
| | | | | Expressed in all |
ACBD5 | Acyl-CoA binding domain containing 5 | Predicted membrane proteins
| | | | | Expressed in all |
ACBD6 | Acyl-CoA binding domain containing 6 | | | | | | Expressed in all |
ACCS | 1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional) | | | | | | Expressed in all |
ACD | Adrenocortical dysplasia homolog (mouse) | | | | | | Expressed in all |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ACER2 | Alkaline ceramidase 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ACER3 | Alkaline ceramidase 3 | Predicted membrane proteins
| | | | | Mixed |
ACHE | Acetylcholinesterase (Yt blood group) | Blood group antigen proteins Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACIN1 | Apoptotic chromatin condensation inducer 1 | Plasma proteins Transporters
| | | | | Expressed in all |
ACKR2 | Atypical chemokine receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
ACKR3 | Atypical chemokine receptor 3 | Cancer-related genes G-protein coupled receptors Predicted membrane proteins
| | | | | Expressed in all |
ACKR4 | Atypical chemokine receptor 4 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
ACLY | ATP citrate lyase | Cancer-related genes Citric acid cycle related proteins Enzymes Plasma proteins
| | | | | Expressed in all |